These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 14147437)

  • 1. A METHOD FOR THE PREPARATION OF HUMAN PLASMINOGEN ON A LARGE SCALE.
    SHAMASH Y; RIMON A; MEGGED A; AVIRAM I
    Vox Sang; 1964; 9():191-201. PubMed ID: 14147437
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunological and hemocoagulative characteristics of serums of rabbits immunized with prothrombin, fibrinolysin (plasmin), fibrinogen and thrombin. (Experimental immuno-coagulopathy)].
    DE NICOLA P; ZANGAGLIA O; SOARDI F
    Riv Emoter Immunoematol; 1959; 6():161-78. PubMed ID: 13814944
    [No Abstract]   [Full Text] [Related]  

  • 3. High molecular weight derivatives of human fibrinogen produced by plasmin. I. Physicochemical and immunological characterization.
    Marder VJ; Shulman NR; Carroll WR
    J Biol Chem; 1969 Apr; 244(8):2111-9. PubMed ID: 4238527
    [No Abstract]   [Full Text] [Related]  

  • 4. FURTHER STUDIES ON THE PURIFICATION AND CHARACTERIZATION OF HUMAN PLASMINOGEN AND PLASMIN.
    ROBBINS KC; SUMMARIA L; ELWYN D; BARLOW GH
    J Biol Chem; 1965 Jan; 240():541-50. PubMed ID: 14253466
    [No Abstract]   [Full Text] [Related]  

  • 5. TWO BATCH METHODS FOR THE PREPARATION OF HIGHLY PURIFIED, PLASMINOGEN-DEFICIENT HUMAN OR BOVINE FIBRINOGEN.
    JOHNSON AJ; PERT J
    Vox Sang; 1963; 8():459. PubMed ID: 14059840
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies in cryofibrinogenemia.
    Zlotnick A; Shahin W; Rachmilewitz EA
    Acta Haematol; 1969; 42(1):8-17. PubMed ID: 4243229
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasminogen and urokinase determination based on the lysis time method. Purification of the substrates--kinetic and methodological studies.
    Berg W
    Acta Med Scand Suppl; 1967; 478():1-45. PubMed ID: 4231608
    [No Abstract]   [Full Text] [Related]  

  • 8. Release of fibrinopeptides from fibrinolytic fibrinogen fragment E.
    Peyer A; Straub PW
    Thromb Diath Haemorrh; 1973 May; 29(2):300-12. PubMed ID: 4271587
    [No Abstract]   [Full Text] [Related]  

  • 9. Separation of human fibrinogen and plasminogen by means of gel filtration.
    BERG W; KORSAN-BENGTSEN K
    Thromb Diath Haemorrh; 1963 Apr; 9():151-4. PubMed ID: 13970621
    [No Abstract]   [Full Text] [Related]  

  • 10. The plasminogen-plasmin system. 8. On the mechanism of chemical induction of fibrinolysis. Isolation of a latent plasminogen activator from human plasma.
    Tomikawa M; Abiko Y
    Thromb Diath Haemorrh; 1973 Feb; 29(1):50-62. PubMed ID: 4267738
    [No Abstract]   [Full Text] [Related]  

  • 11. Different molecular forms of plasminogen and plasmin produced by urokinase in human plasma and their relation to protease inhibitors and lysis of fibrinogen and fibrin.
    Müllertz S
    Biochem J; 1974 Nov; 143(2):273-83. PubMed ID: 4282470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experiences with inhibitors to the plasmin-plasminogen system in the human subject: their modifications by thrombolysin therapy.
    SANDBERG H; TSITOURIS G; BELLET S
    Am J Cardiol; 1960 Aug; 6():432-8. PubMed ID: 14441368
    [No Abstract]   [Full Text] [Related]  

  • 13. QUANTITATIVE ESTIMATION OF UROKINASE AND BACTERIAL PLASMINOGEN ACTIVATORS USING A FIBRIN SUBSTRATE FORMED FROM PLASMINOGEN-FREE FIBRINOGEN.
    ANDERSON AJ
    Biochim Biophys Acta; 1963 Aug; 74():554-7. PubMed ID: 14071603
    [No Abstract]   [Full Text] [Related]  

  • 14. FIBRINOGEN BREAKDOWN PRODUCTS.
    LEWIS JH; WILSON JH
    Am J Physiol; 1964 Nov; 207():1053-7. PubMed ID: 14237449
    [No Abstract]   [Full Text] [Related]  

  • 15. MECHANISM OF HUMAN PLASMINOGEN ACTIVATION BY STREPTOKINASE AND HUMAN PLASMIN.
    BLATT WF; GRAY JL; JENSEN H
    Thromb Diath Haemorrh; 1964 Apr; 11():85-93. PubMed ID: 14167118
    [No Abstract]   [Full Text] [Related]  

  • 16. The antigenic determinant of fibrin(ogen) measured with agglutination inhibition immunoassays.
    Molla A; Donati MB; Vermylen J
    J Clin Pathol; 1974 Jun; 27(6):473-9. PubMed ID: 4137968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of proteolytic activity on the isolation and stability of platelet proteins.
    Ganguly P
    Clin Chim Acta; 1969 Sep; 25(3):371-8. PubMed ID: 4241713
    [No Abstract]   [Full Text] [Related]  

  • 18. [Preparation of anti-human serums. Horse immune serum against human protein for immunoelectrophoresis].
    Zilişteanu C; Mitrică N; Lescinschi S; Potorac E
    Arch Roum Pathol Exp Microbiol; 1964 Dec; 23(4):959-66. PubMed ID: 5836098
    [No Abstract]   [Full Text] [Related]  

  • 19. Rate of activation and electrophoretic mobility of unmodified and partially degraded plasminogen. Effects of 6-aminohexanoic acid and related compounds.
    Thorsen S; Müllertz S
    Scand J Clin Lab Invest; 1974 Oct; 34(2):167-76. PubMed ID: 4278395
    [No Abstract]   [Full Text] [Related]  

  • 20. [STREPTOKINASE INACTIVATION WITH POLYAMINOSTYROL].
    CAVIEZEL O
    Schweiz Med Wochenschr; 1964 Aug; 94():1194-8. PubMed ID: 14257919
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.